Chronic kidney disease management in the United Kingdom: NEOERICA project results - PubMed (original) (raw)
doi: 10.1038/sj.ki.5002273. Epub 2007 Apr 18.
Affiliations
- PMID: 17440495
- DOI: 10.1038/sj.ki.5002273
Free article
Chronic kidney disease management in the United Kingdom: NEOERICA project results
P E Stevens et al. Kidney Int. 2007 Jul.
Free article
Abstract
Early identification of patients with chronic kidney disease (CKD) may allow health-care systems to implement interventions aimed at decreasing disease progression and eventual morbidity and mortality. Primary care in the United Kingdom is computerized suggesting a separate screening program for CKD may not be necessary because identifying data already populates primary care databases. Our study utilized a data set of 163 demographic, laboratory, diagnosis, and prescription variables from 130 226 adults in the regions of Kent, Manchester, and Surrey. The patients were 18 years of age and older in a 5-year study period culminating in November 2003. Estimated glomerular filtration rate was calculated from the four-variable Modification of Diet in Renal Disease equation using calibrated creatinine levels. A valid creatinine value was recorded in almost 30% of this cohort. The age-standardized prevalence of stage 3-5 CKD was 10.6% for females and 5.8% for males. In these patients, the odds ratio for hypertension was 2.1, for diabetes 1.33, and for cardiovascular disease 1.69. Only 20% of the diabetic people with stage 3-5 CKD had a blood pressure less than or equal to 130/80 mm Hg. The proportion of patients with anemia significantly rose as renal function declined. We suggest that stage 3-5 CKD is easily detected in existing computerized records. The associated comorbidity and management is readily available enabling intervention and targeting of specialist resources.
Comment in
- In search of a rational approach to chronic kidney disease detection and management.
Kallen AJ, Patel PR. Kallen AJ, et al. Kidney Int. 2007 Jul;72(1):3-5. doi: 10.1038/sj.ki.5002233. Kidney Int. 2007. PMID: 17597785
Similar articles
- Chronic kidney disease and cardiovascular risk in hypertensive type 2 diabetics: a primary care perspective.
Ravera M, Noberasco G, Re M, Filippi A, Gallina AM, Weiss U, Cannavò R, Ravera G, Cricelli C, Deferrari G. Ravera M, et al. Nephrol Dial Transplant. 2009 May;24(5):1528-33. doi: 10.1093/ndt/gfn692. Epub 2008 Dec 10. Nephrol Dial Transplant. 2009. PMID: 19073656 - Assessing the prevalence, monitoring and management of chronic kidney disease in patients with diabetes compared with those without diabetes in general practice.
New JP, Middleton RJ, Klebe B, Farmer CK, de Lusignan S, Stevens PE, O'Donoghue DJ. New JP, et al. Diabet Med. 2007 Apr;24(4):364-9. doi: 10.1111/j.1464-5491.2007.02075.x. Epub 2007 Feb 28. Diabet Med. 2007. PMID: 17335468 - Who should be targeted for CKD screening? Impact of diabetes, hypertension, and cardiovascular disease.
Collins AJ, Vassalotti JA, Wang C, Li S, Gilbertson DT, Liu J, Foley RN, Chen SC, Arneson TJ. Collins AJ, et al. Am J Kidney Dis. 2009 Mar;53(3 Suppl 3):S71-7. doi: 10.1053/j.ajkd.2008.07.057. Am J Kidney Dis. 2009. PMID: 19231764 - Screening for chronic kidney disease: which strategy?
Hallan SI, Stevens P. Hallan SI, et al. J Nephrol. 2010 Mar-Apr;23(2):147-55. J Nephrol. 2010. PMID: 20155721 Review. - A quick guide to evidence-based chronic kidney disease care for the primary care physician.
Fox CH, Voleti V, Khan LS, Murray B, Vassalotti J. Fox CH, et al. Postgrad Med. 2008 Jul 31;120(2):E01-6. doi: 10.3810/pgm.2008.07.1798. Postgrad Med. 2008. PMID: 18654062 Review.
Cited by
- Anesthetic Challenges in a Pediatric Patient With Chronic Kidney Disease Complicated by Dilated Cardiomyopathy Undergoing Non-cardiac Surgery.
Kore S, Sharma V, Garud I. Kore S, et al. Cureus. 2024 Sep 29;16(9):e70477. doi: 10.7759/cureus.70477. eCollection 2024 Sep. Cureus. 2024. PMID: 39479128 Free PMC article. - Evaluation of cardiac remodeling in pediatric chronic kidney disease by cardiovascular magnetic resonance.
Song S, Xie L, Xu H, Xu K, Fu H, Zhang L, Hou R, Tao Y, Guo Y. Song S, et al. BMC Cardiovasc Disord. 2024 Oct 1;24(1):526. doi: 10.1186/s12872-024-04179-1. BMC Cardiovasc Disord. 2024. PMID: 39354376 Free PMC article. - Research hotspots and future trends in lipid metabolism in chronic kidney disease: a bibliometric and visualization analysis from 2004 to 2023.
Wang Y, Liu T, Liu W, Zhao H, Li P. Wang Y, et al. Front Pharmacol. 2024 Sep 3;15:1401939. doi: 10.3389/fphar.2024.1401939. eCollection 2024. Front Pharmacol. 2024. PMID: 39290864 Free PMC article. - Chronic kidney disease: detect, diagnose, disclose-a UK primary care perspective of barriers and enablers to effective kidney care.
Stewart S, Kalra PA, Blakeman T, Kontopantelis E, Cranmer-Gordon H, Sinha S. Stewart S, et al. BMC Med. 2024 Aug 15;22(1):331. doi: 10.1186/s12916-024-03555-0. BMC Med. 2024. PMID: 39148079 Free PMC article. Review. - Natural antagonistic flavones for AhR inhibit indoxyl sulfate-induced inflammatory gene expression in vitro and renal pathological damages in vivo.
Iwashima T, Takemura Y, Kishimoto Y, Ono C, Watanabe A, Iida K. Iwashima T, et al. Food Nutr Res. 2024 Jul 31;68. doi: 10.29219/fnr.v68.10032. eCollection 2024. Food Nutr Res. 2024. PMID: 39113916 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical